A newly discovered function of LncZFAS1 has emerged, demonstrating its role in negatively regulating NLRP3 inflammasome activation and pyroptosis in human neuroblast cells treated with 1-methyl-4-phenylpyridinium, serving as an in vitro model of Parkinson’s disease [292]. This evidence concerns the gene NLRP3 and Parkinson disease.